192 related articles for article (PubMed ID: 18085684)
21. Polymorphisms of the vincristine pathway and response to treatment in children with childhood acute lymphoblastic leukemia.
Ceppi F; Langlois-Pelletier C; Gagné V; Rousseau J; Ciolino C; De Lorenzo S; Kevin KM; Cijov D; Sallan SE; Silverman LB; Neuberg D; Kutok JL; Sinnett D; Laverdière C; Krajinovic M
Pharmacogenomics; 2014 Jun; 15(8):1105-16. PubMed ID: 25084203
[TBL] [Abstract][Full Text] [Related]
22. Itraconazole-enhanced vincristine neurotoxicity in a child with acute lymphoblastic leukemia.
Jeng MR; Feusner J
Pediatr Hematol Oncol; 2001 Mar; 18(2):137-42. PubMed ID: 11255732
[TBL] [Abstract][Full Text] [Related]
23. Measuring vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia.
Lavoie Smith EM; Li L; Hutchinson RJ; Ho R; Burnette WB; Wells E; Bridges C; Renbarger J
Cancer Nurs; 2013; 36(5):E49-60. PubMed ID: 23842524
[TBL] [Abstract][Full Text] [Related]
24. Vincristine-induced neuropathy as the initial presentation of charcot-marie-tooth disease in acute lymphoblastic leukemia: a Pediatric Oncology Group study.
Chauvenet AR; Shashi V; Selsky C; Morgan E; Kurtzberg J; Bell B;
J Pediatr Hematol Oncol; 2003 Apr; 25(4):316-20. PubMed ID: 12679647
[TBL] [Abstract][Full Text] [Related]
25. Vincristine induced cranial neuropathy.
Dixit G; Dhingra A; Kaushal D
J Assoc Physicians India; 2012 Mar; 60():56-8. PubMed ID: 22799120
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and Toxicity of Vincristine and CYP3A5 Genetic Polymorphism in Rhabdomyosarcoma Pediatric Egyptian Patients.
Shalaby N; Zaki HF; Badary OA; Kamal S; Nagy M; Makhlouf D; Elnashar A; Elnadi E; Abdelshafi SA; Abouelnaga S; Saber MM
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1391-1409. PubMed ID: 38680001
[TBL] [Abstract][Full Text] [Related]
27. Patterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia.
Lavoie Smith EM; Li L; Chiang C; Thomas K; Hutchinson RJ; Wells EM; Ho RH; Skiles J; Chakraborty A; Bridges CM; Renbarger J
J Peripher Nerv Syst; 2015 Mar; 20(1):37-46. PubMed ID: 25977177
[TBL] [Abstract][Full Text] [Related]
28. Pharmacogenetic association with neurotoxicity in Hispanic children with acute lymphoblastic leukaemia.
McClain CA; Bernhardt MB; Berger A; Bernini JC; Marquez-Do D; Winslow R; Scheurer ME; Schafer ES
Br J Haematol; 2018 Jun; 181(5):684-687. PubMed ID: 28419449
[No Abstract] [Full Text] [Related]
29. Prospective randomized trial of interventions for vincristine-related neuropathic pain.
Anghelescu DL; Tesney JM; Jeha S; Wright BB; Trujillo L; Sandlund JT; Pauley J; Cheng C; Pei D; Pui CH
Pediatr Blood Cancer; 2020 Sep; 67(9):e28539. PubMed ID: 32618122
[TBL] [Abstract][Full Text] [Related]
30. Bilateral vocal cord paralysis following treatment with vincristine.
Naithani R; Dolai TK; Kumar R
Indian Pediatr; 2009 Jan; 46(1):68-9. PubMed ID: 19179723
[TBL] [Abstract][Full Text] [Related]
31. Vincristine-induced paralytic ileus during induction therapy of treatment protocols for acute lymphoblastic leukemia in adult patients.
Yasu T; Ohno N; Kawamata T; Kurokawa Y
Int J Clin Pharmacol Ther; 2016 Jun; 54(6):471-3. PubMed ID: 27087157
[TBL] [Abstract][Full Text] [Related]
32. Vincristine-induced neuropathy in pediatric patients with acute lymphoblastic leukemia in Oman: Frequent autonomic and more severe cranial nerve involvement.
Nazir HF; AlFutaisi A; Zacharia M; Elshinawy M; Mevada ST; Alrawas A; Khater D; Jaju D; Wali Y
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28623857
[TBL] [Abstract][Full Text] [Related]
33. Effect of pyridoxine plus pyridostigmine treatment on vincristine-induced peripheral neuropathy in pediatric patients with acute lymphoblastic leukemia: a single-center experience.
Aydin Köker S; Gözmen S; Demirağ B; Ünalp A; Karapinar TH; Oymak Y; Gürbüz G; Öner Eİ; Vergin RC
Neurol Sci; 2021 Sep; 42(9):3681-3686. PubMed ID: 33439396
[TBL] [Abstract][Full Text] [Related]
34. Aggravation of vincristine-induced neurotoxicity by itraconazole in the treatment of adult ALL.
Böhme A; Ganser A; Hoelzer D
Ann Hematol; 1995 Dec; 71(6):311-2. PubMed ID: 8534764
[TBL] [Abstract][Full Text] [Related]
35. Mild axonal neuropathy of children during treatment for acute lymphoblastic leukaemia.
Reinders-Messelink HA; Van Weerden TW; Fock JM; Gidding CE; Vingerhoets HM; Schoemaker MM; Göeken LN; Bökkerink JP; Kamps WA
Eur J Paediatr Neurol; 2000; 4(5):225-33. PubMed ID: 11030069
[TBL] [Abstract][Full Text] [Related]
36. Vincristine-induced peripheral neuropathy in a neonate with congenital acute lymphoblastic leukemia.
Baker SK; Lipson DM
J Pediatr Hematol Oncol; 2010 Apr; 32(3):e114-7. PubMed ID: 20216233
[TBL] [Abstract][Full Text] [Related]
37. Prospective assessment of vincristine-induced peripheral neuropathy in paediatric acute lymphoblastic leukemia.
Li T; Kandula T; Cohn RJ; Kiernan MC; Park SB; Farrar MA
Clin Neurophysiol; 2023 Oct; 154():157-168. PubMed ID: 37633123
[TBL] [Abstract][Full Text] [Related]
38. Reversible vincristine-related flaccid paralysis in a child with acute lymphoblastic leukemia.
Fioredda F; Micalizzi C; Lanciotti M; Dufour C; Lamba LD; Fiocchi I
Med Pediatr Oncol; 2002 Aug; 39(2):141-2. PubMed ID: 12116067
[No Abstract] [Full Text] [Related]
39. Mir-pharmacogenetics of Vincristine and peripheral neurotoxicity in childhood B-cell acute lymphoblastic leukemia.
Gutierrez-Camino Á; Umerez M; Martin-Guerrero I; García de Andoin N; Santos B; Sastre A; Echebarria-Barona A; Astigarraga I; Navajas A; Garcia-Orad A
Pharmacogenomics J; 2018 Dec; 18(6):704-712. PubMed ID: 29282364
[TBL] [Abstract][Full Text] [Related]
40. Switching to Bortezomib may Improve Recovery From Severe Vincristine Neuropathy in Pediatric Acute Lymphoblastic Leukemia.
Joshi J; Tanner L; Gilchrist L; Bostrom B
J Pediatr Hematol Oncol; 2019 Aug; 41(6):457-462. PubMed ID: 31233464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]